501 related articles for article (PubMed ID: 19464064)
21. Bosentan for mild pulmonary vascular disease in ASD patients (the BOMPA trial): a double-blind, randomized controlled, pilot trial.
Van De Bruaene A; Jansen K; De Meester P; Delcroix M; Voigt JU; Gabriels C; Moons P; Budts W
Int J Cardiol; 2013 Oct; 168(5):5081-2. PubMed ID: 23972964
[No Abstract] [Full Text] [Related]
22. Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect.
D'Alto M; Vizza CD; Romeo E; Badagliacca R; Santoro G; Poscia R; Sarubbi B; Mancone M; Argiento P; Ferrante F; Russo MG; Fedele F; Calabrò R
Heart; 2007 May; 93(5):621-5. PubMed ID: 17135220
[TBL] [Abstract][Full Text] [Related]
23. Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study.
Gatzoulis MA; Beghetti M; Galiè N; Granton J; Berger RM; Lauer A; Chiossi E; Landzberg M;
Int J Cardiol; 2008 Jun; 127(1):27-32. PubMed ID: 17658633
[TBL] [Abstract][Full Text] [Related]
24. Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects.
Sitbon O; Beghetti M; Petit J; Iserin L; Humbert M; Gressin V; Simonneau G
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():25-31. PubMed ID: 16919007
[TBL] [Abstract][Full Text] [Related]
25. Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome.
Galie N; Manes A; Palazzini M; Negro L; Marinelli A; Gambetti S; Mariucci E; Donti A; Branzi A; Picchio FM
Drugs; 2008; 68(8):1049-66. PubMed ID: 18484798
[TBL] [Abstract][Full Text] [Related]
26. Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects.
Mehta PK; Simpson L; Lee EK; Lyle TA; McConnell ME; Book WM
Tex Heart Inst J; 2008; 35(3):256-61. PubMed ID: 18941642
[TBL] [Abstract][Full Text] [Related]
27. Targeted therapy is required for management of pulmonary arterial hypertension after defect closure in adult patients with atrial septal defect and associated pulmonary arterial hypertension.
Fujino T; Yao A; Hatano M; Inaba T; Muraoka H; Minatsuki S; Imamura T; Maki H; Kinugawa K; Ono M; Nagai R; Komuro I
Int Heart J; 2015; 56(1):86-93. PubMed ID: 25742945
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary vasoreactivity predicts long-term outcome in patients with Eisenmenger syndrome receiving bosentan therapy.
D'Alto M; Romeo E; Argiento P; Santoro G; Sarubbi B; Gaio G; Mélot C; Russo MG; Naeije R; Calabrò R
Heart; 2010 Sep; 96(18):1475-9. PubMed ID: 20668108
[TBL] [Abstract][Full Text] [Related]
29. Sivelestat attenuates lung injury in surgery for congenital heart disease with pulmonary hypertension.
Nomura N; Asano M; Saito T; Nakayama T; Mishima A
Ann Thorac Surg; 2013 Dec; 96(6):2184-91. PubMed ID: 24075485
[TBL] [Abstract][Full Text] [Related]
30. Effects of pulmonary vasodilator therapy on ventilatory efficiency during exercise in adults with Eisenmenger syndrome.
Yang-Ting S; Aboulhosn J; Sun XG; Child JS; Sietsema KE
Congenit Heart Dis; 2011; 6(2):139-46. PubMed ID: 21418531
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcomes of pulmonary arterial hypertension under specific drug therapy in Eisenmenger syndrome.
Hascoët S; Baruteau AE; Humbert M; Simonneau G; Jais X; Petit J; Laux D; Sitbon O; Lambert V; Capderou A
J Heart Lung Transplant; 2017 Apr; 36(4):386-398. PubMed ID: 27866929
[TBL] [Abstract][Full Text] [Related]
32. [Impact of bosentan therapy on stress-induced pulmonary hypertension in patients with systemic sclerosis].
Volkov AV; Kurmukov IA; Yudkina NN; Glukhova SI; Nikolaeva EV
Ter Arkh; 2015; 87(1):49-56. PubMed ID: 25823269
[TBL] [Abstract][Full Text] [Related]
33. [Pulmonary plasma catecholamine levels and pulmonary hypertension in congenital heart disease].
Knirsch W; Eiselt M; Nürnberg J; Haas NA; Berger F; Dähnert I; Uhlemann F; Lange PE
Z Kardiol; 2002 Dec; 91(12):1035-43. PubMed ID: 12490993
[TBL] [Abstract][Full Text] [Related]
34. Safety and tolerability of bosentan in adults with Eisenmenger physiology.
Gatzoulis MA; Rogers P; Li W; Harries C; Cramer D; Ward S; Mikhail GW; Gibbs JS
Int J Cardiol; 2005 Jan; 98(1):147-51. PubMed ID: 15676179
[TBL] [Abstract][Full Text] [Related]
35. Right ventricular systolic pressure response during exercise in adolescents born with atrial or ventricular septal defect.
Möller T; Brun H; Fredriksen PM; Holmstrøm H; Peersen K; Pettersen E; Grünig E; Mereles D; Thaulow E
Am J Cardiol; 2010 Jun; 105(11):1610-6. PubMed ID: 20494671
[TBL] [Abstract][Full Text] [Related]
36. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial.
Galiè N; Rubin Lj; Hoeper M; Jansa P; Al-Hiti H; Meyer G; Chiossi E; Kusic-Pajic A; Simonneau G
Lancet; 2008 Jun; 371(9630):2093-100. PubMed ID: 18572079
[TBL] [Abstract][Full Text] [Related]
37. Long-term effect of bosentan in pulmonary hypertension associated with complex congenital heart disease.
Baptista R; Castro G; da Silva AM; Monteiro P; Providência LA
Rev Port Cardiol; 2013 Feb; 32(2):123-9. PubMed ID: 23351920
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of 2-d-echocardiographic and hemodynamic findings in patients with atrial and ventricular septal defects (author's transl)].
Schartl M; Schartl S; Disselhoff W; Lange L; Disselhoff M
Z Kardiol; 1982 May; 71(5):370-6. PubMed ID: 7113329
[TBL] [Abstract][Full Text] [Related]
39. Bosentan effects on hemodynamics and clinical outcome in heart failure patients with pulmonary hypertension awaiting cardiac transplantation.
Hefke T; Zittermann A; Fuchs U; Schulte-Eistrup S; Gummert JF; Schulz U
Thorac Cardiovasc Surg; 2012 Feb; 60(1):26-34. PubMed ID: 21432755
[TBL] [Abstract][Full Text] [Related]
40. Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trial.
Baughman RP; Culver DA; Cordova FC; Padilla M; Gibson KF; Lower EE; Engel PJ
Chest; 2014 Apr; 145(4):810-817. PubMed ID: 24177203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
